MedPath

Clinical Study Evaluating Outcomes of Reverse Shoulder Arthroplasty With SMR Stemless

Recruiting
Conditions
Osteo Arthritis Shoulders
Rotator Cuff Tear Arthropathy
Registration Number
NCT04529798
Lead Sponsor
Arthro Medics AG
Brief Summary

The objectives of this study are the assessment of the clinical, radiographical and patient-reported outcomes of SMR Stemless Reverse Shoulder Arthroplasty (LimaCorporate S.p.A.) used as standard of care over a period of at least 2 years of follow-up and the evaluation of the incidence of any complication.

Detailed Description

The focus of this study is the evaluation on clinical, patient-reported and radiographical outcomes of SMR Stemless Reverse Shoulder Arthroplasty. There is a retrospective and prospective study population.

The follow up time-points are (as of standard of care and not different for this study):

* Baseline

* 6 weeks postop

* 6 months postop

* 12 months postop

* 24 months postop

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • rotator-cuff arthropathy, osteoarthritis
  • approving written informed consent
Exclusion Criteria
  • Female patients who are pregnant, nursing, or planning a pregnancy.
  • All adult patients with any of the SMR Stemless contraindication for use for the reverse configuration as reported in the current local Instruction for use.
  • not consenting in participating in this study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Subjective Shoulder Value score5 years

Evaluation of the change of the Subjective Shoulder Value score from pre-operative to the last follow-up visit.

Secondary Outcome Measures
NameTimeMethod
Quick-Dash score5 years

Evaluation of the change of the Quick-Dash score from pre-operative to the last follow-up visit.

ASES Shoulder Score5 years

Evaluation of the change of the ASES shoulder score from pre-operative to the last follow-up visit.

Loosening, implant stability, radiolucent lines1 year

Radiographic evaluation of the implant stability as rate and progression of symptomatic radiolucent lines and loosening.

UCLA shoulder score5 years

Evaluation of the change of the UCLA shoulder score from pre-operative to the last follow-up visit.

VAS pain5 years

Evaluation of the change of the VAS pain score from pre-operative to the last follow-up visit.

Trial Locations

Locations (1)

Arthro Medics AG

🇨🇭

Basel, Basel-Stadt, Switzerland

© Copyright 2025. All Rights Reserved by MedPath